THE human microbiome has been implicated as an important factor in health and disease ([@bib54]); however, the mechanisms by which it influences human physiology are largely unknown. Experiments that manipulate specific genetic, molecular, and microbial components of the microbe--host interface are essential for the dissection of these mechanisms ([@bib52]), but the identification of targets for experimental manipulation remains a significant challenge. However, both microbial community composition and its effects on host health are modulated by host characteristics that exhibit heritable variation ([@bib1]; [@bib3]; [@bib32]; [@bib42]), providing the opportunity to use population systems genetic strategies to identify genetic variants and associated traits to serve as entry points for investigating key functional pathways at the microbe--host interface ([@bib55]; [@bib32]; [@bib22]).

Studies of the gut microbiome have produced convincing evidence for a microbial influence over many host traits including human gastrointestinal disorders ([@bib55]; [@bib22]; [@bib31]), metabolic traits, diabetes ([@bib54]; [@bib52]), and obesity ([@bib32]; [@bib4]; [@bib35]). Perhaps more surprising is the influence of gut microbiota and the metabolites they produce on the brain ([@bib2]; [@bib29]; [@bib5]; [@bib51]) and circadian behaviors such as sleep ([@bib28]). Despite the importance of these microbial influences, the mechanisms of many of these interactions remain unknown.

There have been many well-documented relationships between host genetic variation, intestinal flora composition, and disease reported in human genetic analyses ([@bib11]; [@bib21]; [@bib49]; [@bib17]; [@bib20]; [@bib22]). Because mice and humans harbor similar microbiota at high taxonomic levels ([@bib30]; [@bib25]), systems genetic analysis in laboratory mice can be an effective tool for discovering the mechanisms of host--microbe interactions in a large-scale, data-driven manner. This quantitative genetic approach provides a means of holistic assessment of the relationships between hosts, microbes, and diseases through the use of population genetic variation, one of the greatest determinants of microbial community composition in mice ([@bib11]; [@bib3]). The study of natural genetic variation ([@bib3]) and engineered mutations ([@bib48]; [@bib43]) also enables deep dissection of the biology of the microbiome, and discovery of host genetic loci that regulate microbial abundance ([@bib1]; [@bib32]). The transcriptome of the cecum provides insight into the host microenvironment by quantifying the relative abundances of transcripts encoding host pathways involved in metabolic responses, the production and presentation of cell-surface antigens, and constituents of the immune system, such as the gut-associated lymphoid tissue, among other host processes that both shape and respond to gut microbiota.

The Collaborative Cross (CC) mouse population, ([@bib8]; [@bib6]) constructed from the cross of eight diverse inbred progenitor strains, was designed for high-precision ([@bib36]) and high-diversity systems genetic analysis. The host genetic variation among this population results in diverse microbiome compositions ([@bib3]), and physiological and behavioral phenotypes. This population has been used to identify QTL regulating the abundance of fecal microbes ([@bib42]). Here, we use host transcriptomic, in addition to genetics and microbiome, analysis to find host mechanisms related to disease. Genetic correlations among these characteristics are used to construct systems genetic networks ([Figure 1](#fig1){ref-type="fig"}). Interrogation of these networks at the level of transcripts, microbes, and phenotypes enables the study of mechanisms of microbiota influence on health and disease by identifying causal mechanisms responsible for phenotypic correlations.

![(A) The systems genetic model and gut microbiomics. Genetic variation in a host population together with the environment interact to affect intestinal gene expression in the host, microbial abundance, and disease-related traits in the host. There is significant bidirectional interplay among the microbiome, host gene expression, and disease-related phenotypes; however, the effect of host genotype is unidirectional, and therefore causal. (B) The analysis and decision steps used in this study of the relationship of the microbiome, cecal transcriptome, phenotype, and genotypes of Collaborative Cross mice, and then the analysis used in the validation experiment.](719f1){#fig1}

Here, we integrate data for host genotype, disease-related phenotypes, gut microbiome composition, and associated gut gene expression to develop a systems genetic network for the gut--microbiome interaction and its effects on host health. Specifically, we performed an integrative analysis leveraging cecal messenger RNA (mRNA) levels, luminal microbiome, physiology, and behavior from over 100 incipient strains of the CC population. Through the analysis of relationships among these measurements, we apply systems genetic analysis to identify a microbe involved in sleep disorders.

Materials and Methods {#s1}
=====================

Mice {#s2}
----

The breeding of the CC at Oak Ridge National Laboratory (ORNL) has been described previously ([@bib6]). Mice from each of the eight inbred progenitor strains consisting of five common inbred strains (A/J, C57BL/6J, 129S1/SvImJ, NOD/LtJ, and NZO/HILtJ) and three wild-derived inbred strains (CAST/EiJ, PWK/PhJ, and WSB/EiJ) were randomly assigned to one of a roughly balanced set of breeding schemes, which dictated the order in which strains were crossed. The strains were crossed pairwise to create a G1 generation, and these were crossed pairwise to make the four-way G2 generation, then crossed again to make the G2:F1 generation. The G2:F1s were crossed and the progeny randomly assigned to one of three mating pairs, of which one was randomly chosen as the priority pair to contribute to the next generation. If this mating was nonproductive, the offspring of the next ranked pair were used. To prevent die-out at advanced generations, backcrossing was also used in rare instances. A line was considered lost if no progeny were born after several breeding attempts using these strategies. Phenotyping and genotyping were performed in at least one breeding pair per line from generations G2:F5--G2:F8 for QTL analysis; most genotyped mice came from the G2:F5 generation, which we estimate to be 75% inbred ([@bib36]).

All mice were housed at the William L. and Liane B. Russell Center for Comparative and Functional Genomics at ORNL. All animal protocols were reviewed and approved by the ORNL Institutional Animal Care and Use Committee (\#0367; approval). They were maintained in separate cages either individually or with same-sex siblings, subjected to a light:dark cycle of (14:10), and allowed *ad libitum* access to the standard rodent chow (\#5053; irradiated Purina Diet). Water was delivered via an automatic watering system chlorinated to 3--5 ppm. Cages contained Harlan Softcob bedding, with one nestlet enrichment device in each cage. Of the 650 CC lines initiated, 414 lines with at least a single male or female survived to the G2:F5 generation. Litters were weaned at ∼3 weeks of age into breeding pairs, until they entered the phenotyping protocol. Details of the CC Breeding population can be found in [@bib36].

BKS.Cg-*Dock7^m^* +/+ *Lepr^db^/J* mice (referred to here as db/db mice) were obtained from the Jackson Laboratory production colony, and used for the sleep and *Odoribacter* abundance experiments at The Jackson Laboratory. All animal protocols were reviewed and approved by The Jackson Laboratory Institutional Animal Care and Use Committee (\#010007; approval).

Phenotyping {#s3}
-----------

When grandprogeny were born, members of the CC breeding population were subjected to high-throughput analysis broadly reflecting behavior, morphology, and physiology ([@bib36]). Phenotypes included wildness, activity monitoring in open field, light/dark box, piezo sleep, hot plate, tail-clip, blood chemistry and cell counts, and fasting glucose. Dissection metrics of body weight and length, organ and fat pad weights, and bone composition were used. All CC phenotyping data and protocols are publicly available at the Mouse Phenome Database (phenome.jax.org; accession Chesler3).

Dissection {#s4}
----------

Adult mice were euthanized with carbon dioxide and the cecum dissected. The number of animals varied such that for microbial abundance, 108 male and 108 female unique strains were used, and for genotyping 102 male and 99 female mice were used. Cecal contents were manually extruded and snap frozen. Each strain of mice was separately housed from the other strains, preventing any cohousing caging effects. The cecum tissue was extensively flushed with cold saline to get rid of residual fecal matter and snap frozen in RNAlater. All snap-frozen samples were stored at −80°.

Extraction of microbial genomic DNA {#s5}
-----------------------------------

DNA was extracted and the 16S ribosomal RNA (rRNA) gene amplified from cecum contents using a protocol modified from that of [@bib30]), as previously described ([@bib3]). Approximately 100 mg of cecum contents was added to a 2-ml screw-capped tube containing 1 g of silica/zirconia beads (0.1 mm; BioSpec Products, Bartlesville, OK), 500 μl of phenol:chloroform:isoamyl alcohol (25:24:1), and 210 μl of 20% SDS. Headspace was filled with cold DNA extraction buffer (200 mM Tris at pH 8, 200 mM NaCl, and 20 mM EDTA). Bead tubes were attached to a vortex adapter (MO BIO, Carlsbad, CA) and shaken horizontally at high speed for 10 min. The aqueous phase was washed three times with phenol:chloroform:isoamyl alcohol (25:24:1) in phase gel lock tubes (QIAGEN, Valencia, CA). Nucleic acids were precipitated with 1 vol ammonium acetate (7.5 M) and 2 vol isopropanol, and incubation at −20° for ≥ 1 hr. Precipitated nucleic acids were concentrated by centrifugation at 15,000 × *g* for 15 min then dissolved in TE buffer. RNase A digestion (100 U) was performed for 30 min at 37°. Genomic DNA (gDNA) was precipitated with 0.1 vol sodium acetate (3 M, pH 5.5) and 3 vol ethanol, and incubation at −20° for ≥ 1 hr. Again, DNA was concentrated by centrifugation at 15,000 × *g* for 15 min, and pellets were washed twice with 70% ethanol, air dried, and dissolved in PCR-grade water. Mock extractions without cecum contents were used as negative controls.

Preparation and pyrosequencing of the small subunit rRNA gene amplicon libraries in CC mice {#s6}
-------------------------------------------------------------------------------------------

Amplicon libraries of both V1--2 and V4 regions of the 16S small subunit (SSU) rRNA gene were obtained using protocols we described previously ([@bib3]). Amplification of the V1--2 region was performed in 50-μl reactions composed of 10X polymerase buffer (Invitrogen, Carlsbad, CA), 200 μM each dNTP, 3 mM MgSO~4~, 300 nM of forward primer (MWG Operon, Huntsville, AL), 300 nM reverse primer mix (MWG Operon), 1 U of Platinum Taq DNA Polymerase High Fidelity enzyme (Invitrogen), and 100 ng of gDNA. We used a modification of the 27F primer ([@bib14]) fused to 6-nt multiplexing tags and to the 454-FLX sequencing primer A (5′-GCCTCCCTCGCGCCATCAGxxxxxx**GTTTGATCMTGGCTCAG**-3′), where the x region represents the multiplexing tag and the SSU rRNA primer is bold. A single reverse primer (5′- GCCTTGCCAGCCCGCTCAG**CTGCTGCCTYCCGTA**-3′) modified from [@bib53] was also used. Each amplification began with a denaturation step of 94° for 2 min followed by 25 amplification cycles of 94° for 20 sec, 53° for 30 sec, and 68° for 45 sec. A final extension at 68° for 3 min followed the amplification cycles. All amplicons were visualized on agarose gels for quality and subsequently purified from amplification reactions using Agencourt AMPure reagents (Beckman Coulter, Danvers, MA). A final check of amplicon quality and quantity was performed on an Agilent (Santa Clara, CA) Bioanalyzer using DNA 1000 reagents. Sequencing was performed on a 454-FLX instrument (Roche, Indianapolis, IN) following the manufacturer's recommendations. Amplicon libraries V4 regions of 16S SSU rRNA gene were obtained using barcoded primers and sequenced using a 454-FLX instrument (Roche), using 40 samples per plate.

Operational taxonomic unit-based sequence analysis {#s7}
--------------------------------------------------

We utilized a taxonomy-independent analysis approach that classifies the sequences into operational taxonomic units (OTUs) based on sequence similarity (genetic distance), to avoid skewing the results with taxonomic relationships ([@bib41]). High-throughput sequencing reads from the CC samples were clustered in the same analysis as the previously reported progenitor samples ([@bib3]). Reads were processed using the AmpliconNoise pipeline of [@bib38]. The raw reads were filtered and trimmed using the underlying signal intensities or flowgrams generated by the 454 pyrosequencer. The first uncertain signal in each flowgram was found, *i.e.*, one with a value between 0.5 and 0.7, and the read truncated at this point. If this flow occurred prior to the 360th position in the 800 positions of the FLX Titanium read then it was discarded. In addition, all reads were truncated at the 720th flow. The flowgrams were then denoised using the PyroNoise step of the AmpliconNoise pipeline ([@bib37]), which removes homopolymer errors. The flowgrams were then translated into sequences and further clustered by SeqNoise to eliminate PCR point errors, prior to chimera identification with Perseus. The filtered, denoised, and chimera-checked sequences were then clustered using a hierarchical clustering algorithm with average linkage and OTUs constructed at 3% sequence difference across all samples. Data were also analyzed with respect to taxonomic affiliation of the SSU rRNA gene fragments using the Ribosomal Database Project (RDP) Classifier set at an 80% confidence threshold. Counts of individual sequence hits to each annotated sequence cluster were obtained, providing a quantitative metric of relative microbial abundances at taxonomical classification levels that are comparable across human and mouse. Similarity of microbial profiles within and across mouse strains was evaluated, and host-specific microbial sequence clusters were identified.

Heritability of microbial abundance {#s8}
-----------------------------------

Intraclass correlation coefficients, which are used to estimate broad-sense heritability, were obtained from variance components attributable to progenitor mouse strain and residual error, based on data from a previous study in these strains ([@bib3]). The variance components were estimated using a linear mixed model including strain as a random effect. The strain intraclass correlation coefficients were calculated separately for females and males. The R/lme4 (<http://www.r-project.org>, R 3.1.2) package was used for these calculations (Supplemental Material, Table S1).

Genotyping {#s9}
----------

A custom array using the Illumina iSelect platform for the Infinium system was developed for SNP genotyping as previously reported ([@bib36]). Briefly, this array was based upon a subset of the 11,969 SNPs from the NIEHS-Perlegen SNP combined panel ([@bib58]). The set was designed to discriminate all eight founder haplotypes and was optimized so that, for any SNP on the array, the maximum density of informative markers was used.

mRNA preparation {#s10}
----------------

Each dissected cecum was filled with a solution of 1.5 mM KCl, 96 mM NaCl, 27 mM sodium citrate, 8 mM KH~2~PO~4~, and 5.6 mM Na~2~HPO~4~ (pH 7.3) and incubated at 37°, after which the intestines were rinsed and filled with phosphate-buffered saline, 1.5 mM EDTA, and 0.5 mM dithiothreitol and incubated at 37° in a conical centrifuge tube. After an incubation time of 15 min, the tube was centrifuged at 900 × *g*. The resulting pellet was rinsed three times in phosphate-buffered saline (centrifuged at 900 × *g* for 5 min after each rinse). The resulting cell pellet was suspended in TRIzol (Invitrogen) and RNA was purified by column chromatography, as specified by the manufacturer's protocol. Purified total RNA was fluorescently labeled with riboGreen (Invitrogen) and quantitated using a Spectamax Gemini XPS spectrofluorometer (Molecular Devices). RNA was then prepared for assay by dilution to 50 ng/µl in RNase-free water and transferred to a clean 1.5-ml assay tube.

Whole-genome murine gene expression microarrays {#s11}
-----------------------------------------------

All assay methods conformed to the exact protocol listed in the Whole-Genome Gene Expression Assay Manual. Diluted RNA (11 µl, ∼500 ng) was converted to biotinylated complementary RNA (cRNA) using the Illumina TotalPrep RNA Amplification Kit (Ambion). First, single-stranded cDNA was synthesized from the total RNA using the T7 Oligo (dT) primer, then converted to double-stranded cDNA using a combination of DNA polymerase and RNase H. Second, the cDNA was transcribed to biotinylated cRNA using the T7 enzyme and biotin-labeled NTPs. The resulting cRNA was column purified, quantitated, and diluted to 150 ng/µl in RNase-free water. The sample was then applied to a BeadChip (Illumina Mouse WG-6 v2 BeadChip) and hybridized overnight at 58° to allow the cRNA to anneal to the oligonucleotides corresponding to their specific gene. The BeadChips were then washed, blocked with E1, and fluorescently labeled with streptavidin-Cy3. BeadChips were dried by spinning at 300 rpm for 4 min in a benchtop centrifuge and imaged using the Illumina BeadArray Reader. Image data obtained from the BeadArray Reader were analyzed using BeadStudio version 3.0.19 with Gene Expression module 3.0.14. Rank invariant normalization was used with no background subtraction. We filtered the probes that targeted polymorphic sequences due to the bias introduced by microarray probe-target variation in genetic studies and the high density of mouse polymorphisms in the CC. The probes on the Illumina Mouse WG-6v2.0 BeadChip were tested by comparing the sequenced genomes from the Wellcome Sanger Institute (<https://www.sanger.ac.uk/>) ([@bib57]) to determine if they contained a SNP between the strains. In total, 8972 probes were removed due to SNPs in one of the eight strains, and 36,308 probes remained for subsequent QTL mapping and genetic correlation analysis.

Expression QTL mapping {#s12}
----------------------

For genetic mapping of gene expression, particularly *cis*-expression QTL (eQTL), large effects are detectable when the theoretical minor allele frequency (0.125 of the sample) is found in ≥20 mice ([@bib50]). To map the transcripts as individual traits, a SAS 9.1 (SAS Institute Inc., Cary, NC) heritability calculation was performed and probes/traits with heritability estimate (H^2^) \< 0.30 were removed. This resulted in 1990 probes/traits to be mapped. Mapping of QTL was performed using a modified version of the DOQTL R package (Gatti *et al.* 2014). All genome scans were performed using the scanone() function in the DOQTL package with allele calls as input. A random effect was included to account for kinship effect. The *q*-values were calculated for each QTL to obtain multiple testing-adjusted *P*-values. An alternate model that used the CC mouse haplotypes and existing sequence data from the Sanger Mouse Genomes Project, and other sources, to infer individual mouse genotypes at all loci was used (Gatti *et al.* 2014). This enabled the application of genome-wide association to precisely identify those SNPs that predict phenotypic variation. The SNP association also improves precision, because the association is inferred directly at all polymorphic loci throughout the genome, rather than at specific typed SNPs, which may tag haplotypes with considerable numbers of linked polymorphisms. This latter approach improves statistical power because a single-SNP effect is estimated (one degree of freedom test) in contrast to the eight haplotype-specific effects that were used first.

Mapping QTL for microbial abundance {#s13}
-----------------------------------

In a genetic mapping and correlation study, genetic variation is randomized across the genome in the heterogeneous population, and each genotype is represented by multiple (∼1/8) individuals and segregates against a genetically randomized background. In this study, each mouse line resides in a distinct cage, further randomizing genetic and housing effects. Due to the large numbers of absent microbial OTU's in individual mice, OTUs that were not present in ≥10% of the mice were removed, to ensure adequate power to detect correlations among traits and microbes. Application of this filtering step resulted in 846 OTUs in the incipient CC microbes data set. Each OTU was rank-Z-transformed and subjected to a genome-wide one-dimensional scan. The same methods were applied for the microbial QTL mapping as the eQTLs. The maximum LOD ratio of each OTU was recorded. Since the data were rank-Z-transformed, the first OTU was permuted and scanned 10,000 times to obtain genome-wide significance thresholds per trait. To account for the problem of multiple testing across the OTU's, LOD scores were converted to an empirical *P*-value by calculating the proportion of permuted LOD scores found to be greater than the observed LOD score.

Correlating OTU to behavior {#s14}
---------------------------

Using previously reported phenotypes in the CC breeding population ([@bib36]) we sought to correlate these with the microbial abundance of mice of the same line. We considered mice at generation G2:F5 and beyond. We performed missing value imputation for the behavioral phenotypes by replacing the missing values in G2:F5 with the next available value in the same breeding line, but with a higher generation. For example, if the phenotypic value for a certain mouse at G2:F5 was missing, we replaced this value by the value measured at G2:F6 or the value at G2:F7 if the value at G2:F6 was missing. Next, we removed all behavioral measures and OTUs containing only missing values or entirely zeros because these variables do not contribute to the genetic correlation analysis. There were a total of 205 animals in both data sets with 123 phenotypic measures and 13,618 OTUs. We computed the Kendall rank correlation coefficient (Kendall's τ coefficient) for the behavioral phenotypes with OTUs using the cor.test() function in the R statistical framework (<http://www.r-project.org/>). Kendall's τ is a nonparametric statistic that estimates the ordinal associations between two measures. The sign of the Kendall's τ coefficient determines the direction of the relationship, while the magnitude of the correlation coefficient provides a measure of the strength of the relationship between behavioral phenotype and microbial abundance. Because of the sparse nature of the data, we handled the missing values by deleting all the cases with missing values. We hypothesized that there was no relationship between the behavioral phenotypes and the OTUs. The alternative was that there was a relationship in at least one behavioral phenotype and one of the OTUs. To investigate the relationship between the phenotypes and the OTUs, we performed the Student's *t*-test implemented in the cor.test() function in R to test the hypothesis stated above. To account for the problem of multiple hypothesis testing, we applied the false discovery rate (FDR) adjustment implemented by the qvalue() function in the qvalue \[R package version 1.38.0 ([@bib45])\] package in R.

Antibiotic treatment {#s15}
--------------------

All animal protocols were reviewed and approved by The Jackson Laboratory Institutional Animal Care and Use Committee (\#010007; approval). Mice from a standard Specific Pathogen Free (SPF) colony were administered sulfatrim (19.75 mg/liter sulfamethoxazole + 3.95 mg/liter trimethoprim) and ampicillin (1 g/liter of ampicillin sodium salts, pharmaceutical grade) in their drinking water continuously from 8 weeks of age ([@bib56]). The antibiotic exposure began in the breeding colony and continued into the testing phase. Trio matings of these mice were set up (db/+ × db/+) and the pups and lactating dames from these matings were given antibiotic water or control water continuously on a weekly basis. Sweetener (Equal) was added to the antibiotic and control water (2.5 g/liter). Male and female mice were used; sex was not significantly different and was collapsed across analysis. For sleep phenotyping, BKS.Cg-*Dock7^m^* +/+ *Lepr^db^/*J mice (referred to here as db/db mice) were used. Control db/db *n* = 5, and +/+ or db/+ *n* = 20. Antibiotic-treated db/db mice *n* = 24, and db/+ or +/+ *n* = 70.

Preparation and sequencing of SSU rRNA gene amplicon libraries in mutant and treated mice {#s16}
-----------------------------------------------------------------------------------------

gDNA was extracted from all the samples using the PowerSoil DNA Isolation Kit. V1--3 regions of the 16S rRNA gene were amplified \[27 F (5′-AGAGTTTGATCCTGGCTCAG-3′) and 534R (5′- ATTACCGCGGCTGCTGG-3′)\], barcoded, and sequenced on the Miseq 2 × 300 bp sequencing platform. Data processing, including barcode removal, paired end assembly, quality trimming, and chimera screening were performed using a workflow scripted in Python (File S2). OTUs were generated using the Usearch package (version 8.0.1517), using the parameters indicated in this script. Taxonomical classification was based on RDP classifier 2.10, training set 11.

Sleep phenotyping {#s17}
-----------------

Each mouse was placed in its own chamber atop a piezoelectric sensor for noninvasive sleep--wake scoring using PiezoSleep 1.0 (Signal Solutions, Lexington, KY) for 5-day sleep analysis ([@bib13]; [@bib12]). The tester was always blind to genotype. The mice were randomly assigned to treatment or control groups where practical, and the mice had access to food and water *ad libitum* while in the chamber. The room was maintained on a 12:12-hr light:dark cycle. Mice were placed in the chambers between 9 and 10 [am]{.smallcaps} on day 1, and were removed on day 5 at the same time. The data acquisition computer, food, and water were checked daily; otherwise, the mice remained undisturbed. Measures recorded and analyzed consisted of activity onset, time of peak activity, sleep bout length, and total sleep time. The measure "% time sleep" was calculated for each hour and the 72 hr in the middle of testing, and was used for comparisons between groups. Statistical analyses were conducted using JMP 11 (SAS Institute). The best model is:$$\%\,{Sleep} = \beta_{0}{Treatment+}\beta_{1}{Genotype} + \beta_{2}\left( {{Treatment} \times {Genotype}} \right)_{+}\varepsilon$$where ε is random error. The β-parameters were estimated by ordinary least squares and the type III sum of squares was considered for ε in the ANOVA model. In all cases, the full model was fit and reduced by dropping nonsignificant interactions followed by main effects.

To quantify the cyclic patterns in the sleep--wake behavior, a Fourier decomposition of the sleep percentage time series was computed to identify occurrences of \< 24-hr sleep--wake cycles. Whereas the absolute gradient sum quantifies transitions between sleep--wake-dominated epochs, it does not distinguish between a single rapid change and many smaller ones over the period of interest. The Fourier amplitude is proportional to the cyclic changes between sleep- and wake-dominated epochs. Therefore, the maximum Fourier amplitude corresponding to cyclic activity with periods between 4 and 7 hr, *e.g.*, if no significant cyclic activity is present, is small (typically \< 6). The full linear model was applied as above as well as a *post hoc* Tukey honest significant difference test for pairs of differences.

Graphical modeling {#s18}
------------------

Bayesian networks (BNs) are a subclass of directed probabilistic graphical models that were used to model the relationships between genotype and phenotype ([@bib23]). Briefly, BNs depict the direct and indirect relationships between nodes in the network, and there is a direct relationship between the network topology and the joint distribution. Let *X* and $Q$ be random variables representing the phenotypes and genotypes at SNP markers. Our objective was to learn the structure of the BN, which is an nondeterministic polynomial time (NP)-hard problem ([@bib7]). The local models were described using homogenous conditional Gaussian distributions, which allow for a mixture of discrete (genotypes) and continuous (phenotypes) variables ([@bib27]). We adopted the simplifying assumptions that SNPs are independent (unconnected) and that genotype precedes phenotype in the network structure. Briefly, the conditional distribution for a phenotype, $Y = X_{j}$, with discrete parent $Q_{i}$, with genotype states $g$, and continuous parents $X_{i}\left( {i \neq j} \right)$ can be expressed as:$$P\left( {Y\text{|}Q_{i} = g,X_{i} = x_{i}} \right) = N\left( {\alpha\left( g \right) + \beta\left( g \right)^{T}x_{i},\gamma\left( g \right)} \right)$$where the mean is a regression that depends on both the genotype states and continuous parent phenotypes, but the variance depends only on the genotype states. For count variables, the local models were described using a Poisson regression. The posterior distribution is given as:$$P\left( {G|D} \right){\alpha P}\left( {D|G} \right)P\left( G \right)$$where $P\left( G \right)$ is the prior on the graph and $P\left( {D\text{|}G} \right)$ is the likelihood. We used a noninformative energy prior embedded in a Gibbs distribution with hyperparamater $\tau = 0.01.$ A Markov Chain Monte Carlo (MCMC) model was implemented to sample an ensemble of 1000 network structures from the posterior distribution ([@bib18]); the acceptance rate was 24%. Sex was considered a covariate for each local model. To preserve the data, samples with missing data were only eliminated from the affected local models and not from the global network. Model averaging was performed over the top 40 graphs, ranked by posterior probability, in the ensemble.

Data availability {#s19}
-----------------

The microbial abundance of the progenitor strains is available at the Mouse Phenome Database \[accession Chesler5 (RRID:nif-0000-03160)\]. The gene expression microarray data are deposited at the Gene Expression Omnibus \[(GEO:GSE96924) RRID:SCR_004584\]. The genotypes and microbial abundances from the CC are available through the qtlarchive (RRID:nlx_151757) accession Bubier2, and the MsSeq of db/db animals at the National Center for Biotechnology Information Short Read Archive (SRA) \[(PRJNA561132) RRID:SCR_004891\]. All the QTL are deposited at the Mouse Genome Informatics database (RRID:nif-0000-00096) under accessions 5559705, 5559708, 5559710-5, 5559719-22, and 5559724-8. Figure S1, cecal microbial profile across mouse samples. Figure S2, eQTL map of cecum transcripts in CC mice. Figure S3A, microbes and sleep, and Figure S3B, antibiotic treatment and sleep. Figure S4, sleep phenotyping summary plot of sleep data from db/db antibiotic experiment. Table S1, founder strain intraclass correlations, sequences, and genus mapping based on the RDP. Table S2, heritability and eQTLs. Table S3, piezo sleep data from the db antibiotic study. Table S4, *post hoc* comparison of mean sleep fast Fourier transform (FFT) peak amplitude. Table S5, statistical analysis of sleep plots from Figure S4. File S1, denoised fasta sequences split by individual mice. File S2, commented command line for the MiSeq data analysis. Supplemental material available at figshare: <https://doi.org/10.25386/genetics.11441550>.

Results {#s20}
=======

Microbial community composition of incipient CC mice {#s21}
----------------------------------------------------

The median broad-sense heritability of microbial abundance estimated by intraclass correlation in the CC founder strains data from [@bib3] for each OTU (Table S1) was 0.170, with 339 OTUs having a H^2^ \> 0.3, indicating sufficiently heritable abundance for genetic mapping. We determined the cecal microbial community composition of 206 CC mice of both sexes and 102 breeding lines using 454 pyrosequencing of amplicon libraries of the V4 region of the 16S SSU rRNA gene, revealing 13,632 OTUs. These samples were analyzed concurrently with the founder strains ([@bib3]) to obtain a single set of OTUs for both populations. Taxonomic analysis of all sequences using the RDP naïve Bayesian rRNA classifier ([@bib9], [@bib10]) indicated bacterial diversity similar to that of previously observed communities ([@bib3]); Firmicutes comprised 89% of the microbial community and Bacteroidetes (9%) were the second most abundant phylum (Figure S1). In our previous study of replicate mice from the eight CC progenitor strains, we detected more phyla in the founders, but we show here that there are similar predominating phyla ([@bib3]) in the CC.

Microbial abundance QTL {#s22}
-----------------------

We performed QTL mapping to identify host genetic loci accounting for heritable variation in microbial abundance. There were 18 statistically significant (*q* \< 0.05) microbial abundance (*Micab*) QTL ([Table 1](#t1){ref-type="table"}) among the mapped microbial OTU abundances. The 1.5 LOD C.I.s for the significant QTL range from 2 to 24 Mb in size, with an average size of 7.5 Mb. The size is consistent with previous mapping studies in the CC breeding and inbreed populations ([@bib36]; [@bib42]), and substantially smaller than conventional experimental crosses. This interval size, coupled with the extensive genomic data becoming available for the CC founder population, enables refinement of the QTL down to the level of genes and variants in some cases.

###### Significant QTL for microbial abundance in the cecum of incipient CC mice

  MGI QTL symbol   QTL name                                                                           Chr   Peak LOD score   Peak marker   Position Mm 9 (bp)   1.5 LOD interval   P-value      Size (Mb)   Gene Weaver GSID   
  ---------------- ---------------------------------------------------------------------------------- ----- ---------------- ------------- -------------------- ------------------ ------------ ----------- ------------------ --------
  Micab1           Microbial abundance of Clostridiales Ruminococcaceae Oscillibacter 1               1     8.20             rs32084678    13,279,810           rs6275656          rs31653681   0.0033      6.34               217070
  Micab2           Microbial abundance of Bacteroidales Porphyromonadaceae Paludibacter 2             3     8.23             rs31103355    108,854,325          rs31431100         rs37044521   0.0029      4.09               217071
  Micab3           Microbial abundance of Clostridiales Lachnospiraceae Marvinbryantia 3              3     8.13             rs30089246    37,569,141           rs30552223         rs30158956   0.0037      2.03               217072
  Micab4           Microbial abundance of Clostridiales Lachnospiraceae Roseburia 4                   4     9.57             rs32690134    136,028,098          rs27619452         rs3685172    0.0005      9.45               217077
  Micab5           Microbial abundance of Coriobacteriales Coriobacteriaceae Enterorhabdus 5          5     8.84             rs6377391     119,128,609          rs29633871         rs6354701    0.0009      4.65               217078
  Micab6           Microbial abundance of Clostridiales Lachnospiraceae Sporobacterium 6              5     8.42             rs8265964     138,359,981          rs32246505         rs32318125   0.002       4.00               217079
  Micab7           Microbial abundance of Bacteroidales Porphyromonadaceae Odoribacter 7              7     8.84             rs31494696    77,651,351           rs33107817         rs6373775    0.0009      3.53               217080
  Micab8           Microbial abundance of Clostridiales Ruminococcaceae Lactonifactor 8               7     8.88             rs47611520    47,761,932           rs3661776          rs6176297    0.0009      13.55              217081
  Micab9           Microbial abundance of Bacteroidales Porphyromonadaceae Odoribacter 9              7     8.60             rs31494696    77,651,351           rs33107817         rs6373775    0.0013      4.00               217082
  Micab10          Microbial abundance of Clostridiales Lachnospiraceae Anaerostipes 10               8     9.61             rs32936112    47,123,375           rs6281843          rs31252778   0.0003      14.36              217083
  Micab11          Microbial abundance of Clostridiales Incertae Sedis XIV Blautia 11                 8     9.49             rs33429737    31,919,239           rs6399870          rs50110045   0.0005      5.19               217084
  Micab12          Microbial abundance of Clostridiales Clostridiaceae Caminicella 12                 9     8.29             rs30372085    80,440,479           rs30432532         rs33695839   0.0029      7.37               217092
  Micab13          Microbial abundance of Erysipelotrichales Erysipelotrichaceae Turicibacter 13      10    8.87             rs29327022    88,018,183           rs6338556          rs6265280    0.0009      24.62              217093
  Micab14          Microbial abundance of Bacteroidales Bacteroidaceae *Bacteroides* 14               11    8.14             rs26971743    58,783,410           rs6314621          rs26972849   0.0036      6.30               217094
  Micab15          Microbial abundance of Clostridiales Lachnospiraceae Syntrophococcus 15            15    9.47             rs6388530     93,634,974           rs31931586         rs49819430   0.0005      10.43              217095
  Micab16          Microbial abundance of Bacteroidales Porphyromonadaceae Tannerella 16              19    8.10             rs30320578    47,732,625           rs36280504         rs30760881   0.004       6.39               217096
  Micab17          Microbial abundance of Clostridiales Ruminococcaceae Hydrogenoanaerobacterium 17   X     8.50             rs6292190     155,749,346          rs29276152         rs29306363   0.0017      5.59               217097
  Micab18          Microbial abundance of Clostridiales Lachnospiraceae Lachnobacterium 18            X     8.20             rs6213950     163,790,061          rs8255374          rs31682358   0.0033      3.01               217098

Chr, chromosome; GSID, Gene Set ID; LOD, logarithm of the odds; MGI, Mouse Genome Informatics.

eQTL in the CC cecum {#s23}
--------------------

To characterize the host intestinal state, we profiled mouse mRNA abundance in the cecal tissue surrounding the microbial sample. Transcript abundance estimates were generated for 36,308 microarray probes, representing 27,149 genes. Heritability of transcript abundance exceeded H^2^ = 0.3 for 1990 probes in the founder populations. QTL analysis was performed to identify host genomic regions harboring allelic variants that influence the abundance of each probe, resulting in the detection of statistically significant QTL (*q* \< 0.05) for 1641 probes, corresponding to 1513 genes (Table S2). Of these, 950 loci (57.9%) were *cis*-eQTL (Figure S2), which contain polymorphisms that are proximal to transcript-coding regions. Such loci are useful in identifying expression regulatory mechanisms in the effects of genetic variation on complex traits.

Genetic correlation of microbial abundance to disease-related traits reveals a microbe associated with sleep {#s24}
------------------------------------------------------------------------------------------------------------

Correlation of disease-related traits with underlying biomolecular and microbial characteristics across individuals provides a powerful means to identify previously unknown mechanisms of disease. A total of 122 disease-related behavioral and physiological phenotypes were correlated with the abundance of each OTU using Kendall's τ, revealing 45 trait--microbe correlations (comparison-wise *P* \< 0.05), 26 of which exceeded the multiple testing FDR threshold (*q* \< 0.05) ([@bib44]) ([Table 2](#t2){ref-type="table"}). Of the trait--microbe pairs, 41 contained sleep phenotypes that showed significant comparison-wise Kendall's τ correlations with 10 different microbes, 22 of which had *q* \< 0.05. Among these, OTU 273 *Odoribacter* (order Bacteroidales, family Porphyromonadaceae) was the bacterium consistently correlated with the largest number of phenotypes (21 comparison-wise, 13 family-wise adjusted). Twelve of the family-wise significant correlations were with sleep phenotypes ([Table 2](#t2){ref-type="table"} and Figure S3A).

###### Correlations of disease-related phenotypes to microbial abundance

  Phenotype                                                                              Kendall's τ   *P*-value   *q*-value   Microbe (order, family, genus)                        
  -------------------------------------------------------------------------------------- ------------- ----------- ----------- -------------------------------- -------------------- ------------------
  Peak activity time from dark onset averaged over all baseline days (hr)                0.29          5.12E-06    0.036       Clostridiales                    Lachnospiraceae      *Acetitomaculum*
  Peak activity time from dark onset averaged over all baseline days (hr)                −0.29         7.44E-06    0.049       Bacteroidales                    Bacteroidaceae       *Bacteroides*
  Peak activity time from dark onset after sleep deprivation (hr)                        −0.31         2.27E-06    0.017       Bacteroidales                    Bacteroidaceae       *Bacteroides*
  Average percentage of sleep time over all baseline days (%)                            −0.30         5.24E-06    0.036       Bacteroidales                    Porphyromonadaceae   *Barnesiella*
  Glucose concentration (mmol/liter)                                                     0.31          2.98E-06    0.022       Clostridiales                    Lachnospiraceae      *Coprococcus*
  Peak activity time from dark onset averaged over all baseline days (hr)                0.27          5.37E-06    0.037       Clostridiales                    Lachnospiraceae      *Coprococcus*
  Activity onset averaged over all baseline days (hr)                                    0.32          5.52E-07    0.008       Lactobacillales                  Lactobacillaceae     *Lactobacillus*
  Average of continuous sleep length over dark cycle in 4 full days (sec)                0.31          8.36E-07    0.009       Lactobacillales                  Lactobacillaceae     *Lactobacillus*
  Average of continuous sleep length over dark cycle for all baseline days (sec)         0.32          5.89E-07    0.008       Lactobacillales                  Lactobacillaceae     *Lactobacillus*
  Peak activity time from dark onset averaged over all baseline days (hr)                0.29          4.77E-06    0.034       Lactobacillales                  Lactobacillaceae     *Lactobacillus*
  Tail clip latency (sec)                                                                0.31          1.02E-06    0.010       Lactobacillales                  Lactobacillaceae     *Lactobacillus*
  Creatinine concentration (mmol/liter)                                                  0.47          8.26E-08    0.006       Clostridiales                    Ruminococcaceae      *Lactonifactor*
  Activity onset averaged over all baseline days (hr)                                    −0.29         2.55E-06    0.019       Bacteroidales                    Porphyromonadaceae   *Odoribacter*
  Average of continuous sleep lengths over the light cycle in 4 full days (sec)          −0.29         5.19E-06    0.036       Bacteroidales                    Porphyromonadaceae   *Odoribacter*
  Average of continuous sleep lengths over the light cycle for all baseline days (sec)   −0.28         5.61E-06    0.038       Bacteroidales                    Porphyromonadaceae   *Odoribacter*
  Average of continuous sleep lengths over the dark cycles in 4 full days (sec)          −0.31         1.13E-06    0.011       Bacteroidales                    Porphyromonadaceae   *Odoribacter*
  Average of continuous sleep lengths over the dark cycle for all baseline days (sec)    −0.30         1.90E-06    0.015       Bacteroidales                    Porphyromonadaceae   *Odoribacter*
  Average of continuous sleep lengths over 4 full days (sec)                             −0.31         6.05E-07    0.008       Bacteroidales                    Porphyromonadaceae   *Odoribacter*
  Average of continuous sleep lengths over all baseline days (sec)                       −0.30         1.41E-06    0.012       Bacteroidales                    Porphyromonadaceae   *Odoribacter*
  Peak activity time from dark onset averaged over all baseline days (hr)                −0.31         7.52E-07    0.009       Bacteroidales                    Porphyromonadaceae   *Odoribacter*
  Peak activity time from dark onset after sleep deprivation (hr)                        −0.31         6.24E-07    0.008       Bacteroidales                    Porphyromonadaceae   *Odoribacter*
  Percentage of sleep over a 2-hr period prior to sleep deprivation (%)                  −0.31         1.19E-06    0.011       Bacteroidales                    Porphyromonadaceae   *Odoribacter*
  Percentage of sleep time over the dark cycle of 4 full days (%)                        −0.32         2.80E-07    0.007       Bacteroidales                    Porphyromonadaceae   *Odoribacter*
  Percentage of sleep time over 4 full days (%)                                          −0.33         1.22E-07    0.006       Bacteroidales                    Porphyromonadaceae   *Odoribacter*
  Tail clip latency (sec)                                                                −0.29         3.91E-06    0.028       Bacteroidales                    Porphyromonadaceae   *Odoribacter*
  Average percentage of sleep time over all baseline days (%)                            −0.30         6.44E-06    0.043       Clostridiales                    Lachnospiraceae      *Roseburia*

Genetic regulation of the abundance of Odoribacter {#s25}
--------------------------------------------------

The QTL *Micab7* on chromosome 7 is associated with the relative abundance of *Odoribacter*. The QTL is 3.53 Mb in size and contains 42 genes ([Table 1](#t1){ref-type="table"}). The allelic effects for each of the eight founder strain haplotypes are such that the NZO (New Zealand Obese) allele is associated with increased abundance ([Figure 2, A--C](#fig2){ref-type="fig"}). This is significant because the NZO founder strain is obese and prone to a diabetes phenotype, and previous studies of gut microbiota in obesity- and diabetes-prone mice revealed that *Odoribacter*, *Prevotella*, and *Rikenella* have been found in the microbiota of diabetic *db/db* (BKS.Cg-*Dock7^m^* +/+ *Lepr^db^*/J) mice, and are absent among db/+, +/+ littermates ([@bib16]). The *db/db* mice have also been shown to have abnormal sleep patterns in the form of altered sleep--wake regulation ([@bib26]).

![*Odoribacter* abundance in the cecum. (A) Genome scan showing a significant QTL (*P* \< 0.01) peak on Chr 7. Horizontal lines represent permuted significance thresholds. From the top down: highly significant, *P* \< 0.01; significant, *P* \< 0.05; highly suggestive, *P* \< 0.1; and suggestive, *P* \< 0.63. (B) Detailed QTL map on chromosome 7. Bottom: LOD score across Chr 7. Top: allelic effect plots of eight coefficients of the QTL mixed model representing the effect of each CC founder haplotype on phenotype. The NZO allele on Chr 7 is associated with increased abundance of *Odoribacter* (C) Top: LOD score for SNP association mapping in the QTL support interval (67.1--71.1). Red points indicate SNPs with significant association to *Odoribacter* abundance. Bottom: genes and noncoding RNAs located in the QTL interval. (D) Ingenuity Pathway Analysis of the positional candidate genes together with *Lepr* show a network path through *Vegf*, and involving either *Nr2f2* or *Igf1r*. (E) Inferred network relating sleep, microbe abundance, microbial abundance QTL, expression correlations, and mutant mice. The network is a consensus representation of the 40 most likely Bayesian networks in an MCMC sample. Edge weights correspond to the marginal frequency of each directed edge in the top 40 BNs. Sleep 1 represents the sleep trait corresponding to the average of continuous sleep lengths over 4 full days, and Sleep 2 represents the sleep trait activity onset on the fourth day (hr). CC, Collaborative Cross; Chr, chromosome; MCMC, Markov Chain Monte Carlo.](719f2){#fig2}

We hypothesized that *Odoribacter*, *Lepr*, and sleep are connected through a common mechanism. Specifically, if the mechanism controlling altered sleep phenotype and the presence of *Odoribacter* in *Lepr* mutant *db/db* mice is the same mechanism that underlies the correlation of *Odoribacter* abundance and sleep in the CC mice, then we suspect that there is overlap between one or more of the QTL positional candidates and the *Lepr* pathway, and that the perturbation of the gut microbiota of *db/db* mice should affect sleep patterns.

To investigate whether there is overlap of *Micab7* QTL positional candidate genes and *Lepr*, we performed Ingenuity Pathway Analysis (IPA) on the 42 positional candidates, together with the gene *Lepr*. The most likely pathway from this database (Fisher's exact test *P* \< 10^−14^) contained the positional candidate genes *Nr2f2* and *Igf1r* interacting with *Lepr* through *Vegf* ([Figure 2D](#fig2){ref-type="fig"}).

Causal graphical models for phenotype--genotype networks ([@bib39]) were used to infer the direct and indirect associations among the results of the IPA, including *Lepr*, *Vegfa*, *Vegfb*, *Vegfc*, the two positional candidates *Nr2f2* and *Igf1r*, the leptin pathway, and sleep. The network model included the cecal expression of the gene transcripts together with the abundance of *Odoribacter*, two sleep traits, and the genotypes of the CC mice at the QTL. BNs are described by directed acyclic graphs (DAGs), which can be efficiently decomposed and translated into the joint distribution of variables in the model ([@bib23]). Conditional Gaussian distributions were used to model the relationships between genotype and phenotype, and the network structure was learned using an MCMC sampling scheme ([@bib18]) and averaging over the top structures ([@bib19]). The graphical model was represented as a DAG, which could be efficiently decomposed and translated into the joint distribution of variables in the model. If a QTL was associated with the regulation of the *Vegf* pathway, we would expect to see evidence of a network edge between the genotype and at least one of the two positional candidates, the downstream *Lepr* genes, and the phenotype. Furthermore, this analysis can determine which positional candidate is most likely influenced by the causal variant. In aggregate summaries of the top 40 graphs, a repeatable relationship among the QTL, the positional candidate *Igf1r*, *Odoribacter*, and sleep was observed ([Figure 2E](#fig2){ref-type="fig"}). This relationship was observed in the majority of graphs. Therefore there is a plausible interaction among the QTL, *Igf1r* abundance, the leptin pathway, *Odoribacter*, and sleep.

Broad-spectrum antibiotic treatment alters sleep patterns in Lepr^db^/Lepr^db^ mice {#s26}
-----------------------------------------------------------------------------------

We then evaluated whether the presence of *Odoribacter* in *Lepr^db^* mice could explain the altered sleep behavior reported in these mice. To eliminate *Odoribacter*, mice were given antibiotic treatment continuously from conception. As expected ([@bib40]), this broad-spectrum treatment resulted in increased fecal contents of the cecum observed at dissection in both genotypes (Figure S3B); however, it also resulted in a genotype-specific effect on sleep architecture. The percent sleep time for the antibiotic-treated *db/db* mice over a 72-hr period showed a genotype × treatment interaction in a repeated measure multivariate ANOVA: time × genotype × treatment F~(71,45)~ = 2.1199, *P* = 0.0040 ([Figure 3, A--D](#fig3){ref-type="fig"}), with *post hoc* contrast analysis showing significant (*P* \< 0.001) differences between control *db/db* and all three other groups. The widely used sleep summary measurements, such as % time sleep in the light and dark phases, did not adequately capture the complexity of the differences between the control db and control wild-type strains, without or with antibiotics, as they did not reflect temporal patterns (rhythms) (Figure S4 and Table S5). There were genotype-specific differences between % sleep on day 1, day 2, day 3, and day 5 and in daily averages, which were not affected by treatment. Treatment appears to have had the greatest effect in a genotype-specific manner in the night (1, 2, 3, 4, and average), increasing the sleep time of db/db mice significantly. A Fourier amplitude analysis was performed using the FFT algorithm to identify cyclic patterns in sleep behavior. The amplitude of the Fourier spectrum reflects how dominant or consistent the cyclic pattern is at each frequency (cycles/hr) over the time period analyzed. All groups showed the most dominant peak at a period of 24 hr (∼0.042 cycles/hr) as expected. However, distinctions were seen in the peaks at higher frequencies (subcycles). In particular, strong differences were seen in the amplitudes between 0.14 and 0.25 cycles/hr (corresponding to periods ranging from 4 to 7 hr and highlighted by the vertical broken lines in [Figure 3, A--D](#fig3){ref-type="fig"}). Bout lengths will not necessarily impact these patterns. The peak heights quantify the presence of other (typically shorter) cycles relative to the main circadian cycle. [Figure 3E](#fig3){ref-type="fig"} shows the maximum amplitudes in the highlighted range for each mouse in the experimental groups. These show a significant genotype × treatment effect (F~(3,120)~ = 12.2193, *P* \< 0.0001), and an individual least squares means Student's *t*-test showed significant differences between control db/db mice and all three other groups (Table S4).

![Mean and SE for the "% time sleep" over a 5-day test, with cyclic patterns characterized on the right by an FFT of the mean sleep percentage time series. (A) WT water only, (B) db/db mice water (C), WT given antibiotics, and (D) db/db mice given antibiotics. Genotype and antibiotic treatment have a significant interaction affecting "% Sleep" time. Night and day cycles shown with white and black bars, respectively. The FFT amplitudes of the regions of the % Sleep graphs in white are summarized in the graphs on the right. Percent sleep time for the antibiotic-treated *db/db* mice over a 72-hr period showed a genotype × treatment interaction in a repeated measure multivariate ANOVA; time × genotype × treatment F~(71,45)~ = 2.1199, *P* = 0.0040 ([Figure 3, A--D](#fig3){ref-type="fig"}). *Post hoc* contrast analysis revealed significant (*P* \< 0.001) differences between control *db/db* mice and all three other groups (*P* \< 0.001). (E) FFT peak amplitudes for each mouse corresponding to sleep percentage cycles, with periods ranging from 4 to 7 hr (shown with the dotted lines) during the final 4 days of the sleep cycle, shows significant genotype × treatment interaction as well as the db/db control being significantly different from the other three groups. (F) Two of the microbes present in the control db/db mice, but absent in the db/db antibiotic-treated mice. FFT, fast Fourier transform; WT, wild-type.](719f3){#fig3}

V4 sequencing of cecal contents from *db/db* mice showed seven microbial taxonomic units that were absent in the antibiotic-treated db/db case and elevated in the water vehicle (aspartame) control db/db, including two from the family containing *Odoribacter* ([Figure 3F](#fig3){ref-type="fig"}; SRA: PRJNA561132). Thus, the differential abundance of these seven microbial taxa, including *Odoribacter* abundance, is associated with genotype-specific effects of antibiotics on sleep architecture. It is possible that effects on other microbes, or other genotype-specific antibiotic effects, are responsible for the db/db-specific sleep pattern restoration; however, the systems genetic causal network analysis suggests that variation in *Odoribacter* abundance is the likely regulator of sleep architecture.

Discussion {#s27}
==========

Using systems genetics and integrative functional genomics in the CC population, we traversed biological networks of genotypes, gene expression, microbes, and disease-related phenotypes to identify a host--microbe mechanism underlying sleep-related phenotypes. The high allelic variation and precision of the incipient CC mouse population allowed us to map loci that control the abundance of 18 particular microbes, which could be further decomposed using SNP analysis, haplotype association, and gene prioritization methods. Intestinal transcriptome profiling resulted in the detection of ∼1600 significant eQTL, and multiple clusters of transcripts and microbes, whose abundances are jointly modified by genetic variation. Through genetic correlation network analysis, we related these systems genetic networks to disease-related phenotypes obtained in the same population of mice. Causal network analysis and host genetic effects provided insight into the direction of host--microbe disease interactions.

Allelic variants influence the structure of microbial communities by creating conditions that promote or inhibit colonization by certain species ([@bib43]). One way in which allelic variation manifests its effects is through the direct, or indirect, alteration of transcript abundance and the host environment, thereby impacting colonization. Other sources of variation may influence transcript abundance, including the presence of microbiota and their metabolites, disease states, and environmental variation. These sources of variation, and their association with microbiota and disease, can be detected through genetic correlation and probabilistic network analyses. By identifying network components and assessing causal relationships among them through experimental perturbation, it is possible to understand the mechanisms of these relationships.

Genetic correlation from mouse phenotype to microbial abundance enabled the identification of host and microbe influences on sleep architecture. The general role of microbes in sleep, particularly in the cytokine response to infection, is well documented ([@bib24]). Previous work in rabbits ([@bib47]) has shown that altered sleep patterns occur in response to an infectious challenge and that the sleep response is related to the type of infectious organism. Here, we report for the first time the relationship between the abundance of a specific microbe and sleep. OTU273 *Odoribacter* (Bacteroidales, Porphyromonadaceae) abundance is associated with the *Micab7* QTL and was correlated with multiple sleep phenotype measures. Genomic network analyses revealed that the primary candidate gene for the QTL is *Igf1r*, a gene likely to function in the regulation of sleep as the somatotropic axis, IGF-1 signaling, and sleep are intimately related ([@bib34]). Perturbation of this pathway in the db/db *Lepr* mutant mouse is associated with abnormal phenotype and an elevated abundance of *Odoribacter*, albeit among other microbes. Both of these phenomena can be restored to normal values through antibiotic treatment. The observation that indigenous microbes could affect sleep patterns suggests the potential for probiotic or small-molecule metabolite development for the adjustment of sleep patterns in those with clinical sleep disorders. Other studies indicate a relationship between microbiota abundance and ultradian rhythms ([@bib46]), and microbes of the *Odoribacter* were among five genera that decreased in feces in an intermittent hypoxia model of sleep apnea ([@bib33]).

The distinct changes to the sleep architecture and rhythms in, specifically, db/db mice in response to antibiotics are very interesting. The FFT shows the polyphasic *vs.* more monophasic sleep--wake pattern during the light and dark periods. This pattern is clearly visible and distinguishable by eye ([Figure 3, A--D](#fig3){ref-type="fig"}), and is best quantified with the FFT amplitude between 4 and 7 hr (in [Figure 3E](#fig3){ref-type="fig"}). This erratic pattern of sleep and wake may or may not be pathological, but it is clearly abnormal; however, we have not observed it in any of the common inbred strains or in wild mice that we have recently examined ([@bib36])

In these studies, we utilized systems genetic networks to identify, model, and validate the relationships among host genetics, genomics, microbiota, and disease. The mouse provides an efficient, well-controlled system in which to employ this approach, although it is amenable to application in human populations. We demonstrated that using mouse genetics, we can identify relationships that can be extrapolated to humans, though well-known issues in mechanistic conservation and direct translation must be considered. For example, despite high conservation across human and mouse genomes, specific biological mechanisms are not always entirely conserved, although the functional outputs of pathways and involvement in disease may be. Our approach to this challenge is to exploit network overlap, and to identify elements of mouse networks that can be translated to human genetic and genomic networks, which we expect to function similarly but perhaps differ in the details of specific allelic variants, genetic mechanisms, and particular microbiota involved. By developing our study around the holistic quantitation of both host and microbe, in contrast to typical studies of individual gene or treatment effects on microbiota, we are able to generate multiscale networks amenable to integration and extrapolation to disease mechanisms. Much remains to be done in the functional validation of the conservation of these mechanisms.

In all studies of the interplay between host environment, microbiota, and disease, the causal mechanisms underlying associations must be considered. Genetic variation influences the host environment, creating conditions that are hospitable or inhospitable ecological niches for gut microbiota, and can therefore be used to anchor a causal network. Identifying the precise causal genetic variants underlying microbial composition is a lengthy process that has become more tractable with deep sequencing of the CC founders, high-precision mapping populations including the Diversity Outbred derived from the CC, and the ability to integrate functional genomic data from other sources including epigenetic modification, noncoding variants, and disease associations. Although we have demonstrated that the QTL *Micab7* is associated with *Odoribacter* abundance, we have not yet demonstrated whether *Igf1r* variation is indeed the specific causal regulator of this phenotype, whether this locus is associated with abnormal *Odoribacter* abundance, and whether inoculation of *Lepr* or *Igf1r* mice with *Odoribacter* and its metabolites influences sleep. These extensive experimental manipulation studies will provide further evaluation of the causal network that we have identified. Alternatively the metabolites involved in this phenomenon may prove more feasible to identify and manipulate.

By exploiting genetic heterogeneity among organisms, we were able to extract mechanistic relationships between host, microbe, and disease. The systems genetic strategy employed herein provides a wealth of data resources that can be further interrogated by investigators with an interest in specific host genes, variants, microbes, and disease-related phenotypes. Furthermore, the strategy we present here can be readily deployed in other genetically diverse populations to provide efficient, holistic assessment of microbial and host mechanisms of disease. Extracting these disease-relevant mechanistic networks will provide insight into the complex interplay of host and microbe, revealing potential sources of disease etiology and points for therapeutic intervention.
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